Gossamer Bio, Inc. (GOSS)
10.02
+0.25
(+2.56%)
USD |
NASDAQ |
Oct 28, 11:33
Gossamer Bio Price : 10.02 for Oct. 28, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 27, 2026 | 9.17 | 9.87 | 9.10 | 9.77 | 138044.0 |
| Oct 26, 2026 | 9.61 | 9.644 | 8.68 | 9.15 | 250873.0 |
| Oct 23, 2026 | 9.40 | 9.77 | 9.00 | 9.605 | 144834.0 |
| Oct 22, 2026 | 9.73 | 9.965 | 9.34 | 9.46 | 190612.0 |
| Oct 21, 2026 | 9.50 | 10.39 | 9.50 | 9.79 | 218976.0 |
| Oct 20, 2026 | 8.41 | 9.625 | 8.29 | 9.58 | 214553.0 |
| Oct 19, 2026 | 8.80 | 8.885 | 8.310 | 8.43 | 181016.0 |
| Oct 16, 2026 | 8.88 | 8.995 | 8.510 | 8.77 | 171143.0 |
| Oct 15, 2026 | 8.86 | 9.18 | 8.73 | 8.89 | 197801.0 |
| Oct 14, 2026 | 9.59 | 9.641 | 8.77 | 8.905 | 361187.0 |
| Oct 13, 2026 | 9.83 | 10.03 | 9.26 | 9.76 | 478646.0 |
| Oct 12, 2026 | 9.54 | 9.54 | 8.99 | 9.28 | 155209.0 |
| Oct 09, 2026 | 9.93 | 10.10 | 9.20 | 9.31 | 290997.0 |
| Oct 08, 2026 | 10.02 | 10.28 | 9.657 | 9.88 | 197410.0 |
| Oct 07, 2026 | 10.38 | 10.66 | 9.774 | 10.18 | 280653.0 |
| Oct 06, 2026 | 10.77 | 10.93 | 10.50 | 10.78 | 197219.0 |
| Oct 05, 2026 | 10.70 | 10.99 | 10.00 | 10.65 | 391009.0 |
| Oct 02, 2026 | 11.19 | 11.19 | 10.19 | 10.71 | 236381.0 |
| Oct 01, 2026 | 11.63 | 12.14 | 10.80 | 10.93 | 352082.0 |
| Sep 30, 2026 | 11.53 | 12.46 | 11.16 | 11.85 | 382024.0 |
| Sep 29, 2026 | 11.68 | 11.84 | 11.21 | 11.58 | 384008.0 |
| Sep 28, 2026 | 10.46 | 11.85 | 10.33 | 11.52 | 516474.0 |
| Sep 25, 2026 | 10.93 | 11.01 | 10.22 | 10.94 | 426585.0 |
| Sep 24, 2026 | 10.76 | 11.68 | 10.75 | 10.93 | 236250.0 |
| Sep 23, 2026 | 11.69 | 11.97 | 10.03 | 10.99 | 455817.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| United Therapeutics Corp. | 587.55 |
| Arbutus Biopharma Corp. | 4.295 |
| Kura Oncology, Inc. | 10.42 |
| ACADIA Pharmaceuticals, Inc. | 20.25 |
| Alnylam Pharmaceuticals, Inc. | 225.16 |
Price Related Metrics
| PS Ratio | 0.5979 |
| PEG Ratio | -0.0131 |
| Earnings Yield | -555.5% |
| Market Cap | 61.23M |
| PEGY Ratio | -0.0131 |